Impax Laboratories (IPXL) CEO Larry Hsu plans to retire, although he'll remain in his position,...


Impax Laboratories (IPXL) CEO Larry Hsu plans to retire, although he'll remain in his position, and as a board member, until a replacement is hired. Investors seem to be pleased as shares rise 6.1% at the open. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs